N. Yasui-Furukori

发表

Lithium in Tap Water and Suicide Mortality in Japan

T. Terao, N. Ishii, N. Iwata, 2013, International journal of environmental research and public health.

Factor structure of the University Personality Inventory in Japanese medical students

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2020, BMC psychology.

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia

Norio Sugawara, N. Yasui-Furukori, T. Sumiyoshi, 2019, Front. Psychiatry.

The Effect of Aging on the Relationship between the Cytochrome P450 2C19 Genotype and Omeprazole Pharmacokinetics

M. Sasaki, N. Yasui-Furukori, Yukio Ishizawa, 2005, Clinical pharmacokinetics.

Relationship Between Dietary Patterns and Cognitive Function in a Community-Dwelling Population in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2015, Asia-Pacific journal of public health.

Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes.

N. Yasui-Furukori, M. Miura, Toshio Suzuki, 2005, Chirality.

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2016, Neuropsychiatric disease and treatment.

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Carbamazepine Decreases Antihypertensive Effect of Nilvadipine

N. Yasui-Furukori, T. Tateishi, N. Yasui‐Furukori, 2002, Journal of clinical pharmacology.

The Effects of Fluvoxamine on the Steady-State Plasma Concentrations of Escitalopram and Desmethylescitalopram in Depressed Japanese Patients

N. Yasui-Furukori, Kazuhiko Nakamura, Y. Inoue, 2016, Therapeutic drug monitoring.

Preanalysis Storage Conditions Influence the Measurement of Brain-Derived Neurotrophic Factor Levels in Peripheral Blood

Norio Sugawara, N. Yasui-Furukori, S. Tsuchimine, 2014, Neuropsychobiology.

The (R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers

N. Yasui-Furukori, Y. Akamine, S. Yamada, 2013, European Journal of Clinical Pharmacology.

Hydroxylation of R(+)- and S(−)-Omeprazole after Racemic Dosing are Different among the CYP2C19 Genotypes

N. Yasui-Furukori, Y. Akamine, S. Yamada, 2012, Pharmaceutical Research.

Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes.

N. Yasui-Furukori, H. Shiohira, T. Uno, 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations

M. Hayakari, N. Yasui-Furukori, T. Niioka, 2007, European Journal of Clinical Pharmacology.

Effects of multiple‐dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers

N. Yasui-Furukori, M. Miura, I. Ieiri, 2015, Journal of Clinical Pharmacy and Therapeutics.

Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy.

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2019, Journal of clinical psychopharmacology.

Association between oxidative stress-related genes polymorphisms and metabolic abnormalities among schizophrenia patients

Norio Sugawara, N. Yasui-Furukori, K. Oniki, 2017 .

Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study

Norio Sugawara, N. Yasui-Furukori, K. Oniki, 2016, Psychiatry Research.

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study.

Norio Sugawara, N. Yasui-Furukori, K. Maruo, 2021, Journal of Alzheimer's disease : JAD.

Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study

Norio Sugawara, N. Yasui-Furukori, K. Maruo, 2021, Journal of Alzheimer's Disease.

Body mass index and quality of life among outpatients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2013, BMC Psychiatry.

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2021, Neuropsychopharmacology reports.

Relationship of Prolactin Concentrations to Steady-state Plasma Concentrations of Aripiprazole in Schizophrenia Patients.

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2020, Therapeutic drug monitoring.

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole

N. Yasui-Furukori, M. Miura, H. Kagaya, 2006, Xenobiotica; the fate of foreign compounds in biological systems.

The Effects of Ginkgo biloba Extracts on the Pharmacokinetics and Pharmacodynamics of Donepezil

N. Yasui-Furukori, S. Kaneko, T. Tateishi, 2004, Journal of clinical pharmacology.

Dose-Dependent Interaction of Paroxetine With Risperidone in Schizophrenic Patients

N. Yasui-Furukori, S. Kaneko, M. Saito, 2005, Journal of clinical psychopharmacology.

Effects of nutritional education on weight change and metabolic abnormalities among patients with schizophrenia in Japan: A randomized controlled trial.

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2018, Journal of psychiatric research.

Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.

N. Yasui-Furukori, M. Miura, Toshio Suzuki, 2005, British journal of clinical pharmacology.

Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.

A. Munakata, N. Yasui-Furukori, T. Uno, 2005, British journal of clinical pharmacology.

Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.

N. Yasui-Furukori, R. Vries, S. Kaneko, 2005 .

Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study.

Yoshinao Abe, N. Yasui-Furukori, M. Aoki, 2004, Japanese journal of clinical oncology.

Factor structure of the Liebowitz Social Anxiety Scale in community‐dwelling subjects in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Psychiatry and clinical neurosciences.

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2016, Neuropsychiatric disease and treatment.

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2011, Annals of general psychiatry.

Prevalence of metabolic syndrome among patients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Nakaji, 2010, Schizophrenia Research.

Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers

N. Yasui-Furukori, M. Miura, H. Kagaya, 2010, Xenobiotica; the fate of foreign compounds in biological systems.

Effects of the P-glycoprotein Inducer Carbamazepine on Fexofenadine Pharmacokinetics

N. Yasui-Furukori, S. Kaneko, Y. Akamine, 2009, Therapeutic drug monitoring.

Steady-State Pharmacokinetics of a New Antipsychotic Agent Perospirone and Its Active Metabolite, and Its Relationship with Prolactin Response

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2004, Therapeutic drug monitoring.

Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma

N. Yasui-Furukori, T. Niioka, Mikiko Shimizu, 2007, Cancer Chemotherapy and Pharmacology.

Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome.

N. Yasui-Furukori, K. Otani, A. Suzuki, 2001, The American journal of psychiatry.

Tandospirone-Induced Rhabdomyolysis

N. Yasui-Furukori, Kensuke Miyazaki, M. Otaka, 2018, Clinical neuropharmacology.

Effects of selective serotonin reuptake inhibitors on the pharmacokinetics of proton pump inhibitors

N. Yasui-Furukori, Y. Akamine, T. Hirano, 2017 .

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Tsuchimine, 2015, PloS one.

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics

T. Onitsuka, K. Ohi, N. Yasui-Furukori, 2022, Frontiers in Psychiatry.

Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.

N. Yasui-Furukori, S. Kaneko, Tetsu Tomita, 2013, Clinical neuropharmacology.

Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation

K. Yamakawa, N. Yasui-Furukori, H. Osaka, 2007, Epilepsy Research.

Neuroleptic malignant syndrome induced by lamotrigine.

Norio Sugawara, N. Yasui-Furukori, Masamichi Ishioka, 2013, Clinical neuropharmacology.

Association of the Taq I A Polymorphism of the Dopamine D 2 Receptor Gene With Predisposition to Neuroleptic Malignant Syndrome

N. Yasui-Furukori, K. Otani, A. Suzuki, 2001 .

Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.

N. Yasui-Furukori, Mikiko Shimizu, T. Uno, 2006, British journal of clinical pharmacology.

Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity.

N. Yasui-Furukori, T. Uno, T. Takahata, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.

K. Kasai, T. Kishimoto, Tadasu Horai, 2022, Asian journal of psychiatry.

Toward recovery in schizophrenia: Current concepts, findings, and future research directions

Y. Hirano, T. Onitsuka, K. Miura, 2022, Psychiatry and clinical neurosciences.

The relationship between schizophrenia patients' attitudes towards physical health and the prevalence of metabolic syndrome

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2020, Clinical Neuropsychopharmacology and Therapeutics.

Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2016, Schizophrenia Research.

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2020, Neuropsychiatric disease and treatment.

NDT_A_269619 2229..2236

Norio Sugawara, N. Yasui-Furukori, Y. Ozeki, 2020 .

Insulinoma resembling a rapid eye movement sleep behavior disorder: a case report

N. Yasui-Furukori, Kazuhiko Nakamura, K. Kishi, 2019, International medical case reports journal.

Heidenhain variant of Creutzfeldt–Jakob disease resembles dementia with Lewy bodies

Norio Sugawara, N. Yasui-Furukori, Shigeto Oyama, 2020, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study.

T. Onitsuka, K. Ohi, N. Yasui-Furukori, 2022, Asian journal of psychiatry.

Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia

N. Yasui-Furukori, A. Suzuki, T. Kondo, 2007, Psychiatry and clinical neurosciences.

Clinical implications of pharmacogenetics of antidepressants

N. Yasui-Furukori, K. Otani, A. Suzuki, 2002 .

Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam.

N. Yasui-Furukori, S. Kaneko, T. Kondo, 2003, British journal of clinical pharmacology.

Effect of Itraconazole on Pharmacokinetics of Paroxetine: The Role of Gut Transporters

N. Yasui-Furukori, T. Niioka, S. Kaneko, 2007, Therapeutic drug monitoring.

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P‐glycoprotein in risperidone disposition

N. Yasui-Furukori, M. Saito, T. Tateishi, 2005, Clinical pharmacology and therapeutics.

Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects.

A. Munakata, S. Sasaki, K. Okumura, 2003, Life sciences.

Effect of age and disease on bone mass in Japanese patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Annals of General Psychiatry.

Effect of age and sex on prescriptions for outpatients with bipolar disorder in the MUSUBI study: a cross‑sectional study

R. Yoshimura, A. Nakagawa, N. Yasui-Furukori, 2022, Annals of General Psychiatry.

Working status of caregivers for people with dementia: Analysis data from a Japanese Nationwide Survey

Norio Sugawara, N. Yasui-Furukori, K. Maruo, 2020, PloS one.

Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese

N. Yasui-Furukori, S. Kaneko, M. Saito, 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes.

N. Yasui-Furukori, M. Miura, H. Kagaya, 2006, British journal of clinical pharmacology.

Psychotropic Drug–Drug Interactions Involving P-Glycoprotein

N. Yasui-Furukori, I. Ieiri, Y. Akamine, 2012, CNS Drugs.

Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study.

N. Yasui-Furukori, Mikiko Shimizu, T. Uno, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals

N. Yasui-Furukori, S. Kaneko, S. Tsuchimine, 2013, PloS one.

Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes.

N. Yasui-Furukori, A. Suzuki, S. Kaneko, 2004, British journal of clinical pharmacology.

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine

N. Yasui-Furukori, J. Saruwatari, Norio Yasui-Furukori, 2014, BMJ Open.

Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis

N. Yasui-Furukori, K. Oniki, J. Saruwatari, 2016, Pharmacogenetics and genomics.

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2018, Neuropsychiatric disease and treatment.

No association between bone mass and prolactin levels among patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2011, Human psychopharmacology.

Poor Reliability of Therapeutic Drug Monitoring Data for Haloperidol and Bromperidol Using Enzyme Immunoassay

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2003, Therapeutic drug monitoring.

Real-world predictors of changes in fear of COVID-19 in the Japanese general population: a large-scale internet-based cohort study with 20,712 participants

Norio Sugawara, N. Yasui-Furukori, Keita Tokumitsu, 2024, BMC psychiatry.

The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer’s disease than MMSE alone

Norio Sugawara, N. Yasui-Furukori, K. Shimoda, 2021, PloS one.

Dietary patterns are associated with obesity in Japanese patients with schizophrenia

Manabu Saito, Norio Sugawara, N. Yasui-Furukori, 2014, BMC Psychiatry.

No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Human psychopharmacology.

Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Association between the dopamine D2 receptor (DRD2) polymorphism and the personality traits of healthy Japanese participants

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Mutational analysis of CACNA1G in idiopathic generalized epilepsy

K. Yamakawa, A. Delgado-Escueta, P. Lory, 2007, Human mutation.

Higher plasma leptin and lower C-peptide levels are associated with depression: A cross-sectional study.

T. Kudo, N. Yasui-Furukori, K. Hirota, 2019, Journal of affective disorders.

Items of the Montgomery-Åsberg Depression Rating Scale Associated With Response to Paroxetine Treatment in Patients With Major Depressive Disorder

N. Yasui-Furukori, Kazuhiko Nakamura, S. Kaneko, 2016, Clinical neuropharmacology.

Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report

N. Yasui-Furukori, T. Kondo, K. Otani, 2001, European Archives of Psychiatry and Clinical Neuroscience.

Age and gender differences in the factor structure of the Center for Epidemiological Studies Depression Scale among Japanese working individuals.

Norio Sugawara, N. Yasui-Furukori, S. Nakaji, 2015, Comprehensive psychiatry.

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2014, Neuropsychiatric disease and treatment.

Dose-Dependent Effects of Adjunctive Treatment With Aripiprazole on Hyperprolactinemia Induced by Risperidone in Female Patients With Schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2010, Journal of clinical psychopharmacology.

Effect of grapefruit juice in relation to human pharmacokinetic study.

N. Yasui-Furukori, T. Uno, N. Yasui‐Furukori, 2006, Current clinical pharmacology.

Drug-Drug Interactions of P-gp Substrates Unrelated to CYP Metabolism.

N. Yasui-Furukori, Y. Akamine, T. Uno, 2019, Current drug metabolism.

The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.

N. Yasui-Furukori, I. Tamai, M. Miura, 2015, Drug metabolism and pharmacokinetics.

Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers

H. Kusuhara, N. Yasui-Furukori, I. Tamai, 2014, European Journal of Clinical Pharmacology.

Effect of Coadministration of Single and Multiple Doses of Rifampicin on the Pharmacokinetics of Fexofenadine Enantiomers in Healthy Subjects

H. Kusuhara, Y. Sugiyama, N. Yasui-Furukori, 2013, Drug Metabolism and Disposition.

Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers.

N. Yasui-Furukori, M. Miura, Y. Akamine, 2012, British journal of clinical pharmacology.

Different Effects of Three Transporting Inhibitors, Verapamil, Cimetidine, and Probenecid, on Fexofenadine Pharmacokinetics

N. Yasui-Furukori, Kazunobu Sugawara, Norio Yasui-Furukori, 2005, Clinical pharmacology and therapeutics.